Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Natco Pharma Ltd (NATCOPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11536)・商品コード:DATA904C11536
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:36
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn’s disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It operates API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Natco Pharma Ltd (NATCOPHARM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 12
Licensing Agreements 13
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 13
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 14
Equity Offering 15
Natco Pharma Plans to Raise up to USD232 Million in Public Offering of Shares 15
Natco Pharma Raises USD54.5 Million in Private Placement of Shares 16
Natco Pharma Completes Private Placement Of Shares For US$18 Million 17
Debt Offering 18
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 18
Acquisition 19
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 19
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 20
Natco Pharma Ltd – Key Competitors 21
Natco Pharma Ltd – Key Employees 22
Natco Pharma Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Nov 05, 2018: NATCO records INR 583.40 Crores consolidated revenue and INR 181.50 crore of profit, after tax, for the second quarter, FY 2018-19 25
Aug 08, 2018: NATCO records INR 574.5 Crores consolidated revenue and INR 181.1 Crore of profit, after tax, for the First Quarter, FY2018-19 26
May 23, 2018: NATCO records INR 2,242 Crore consolidated revenue and INR 695 Crore of profit, after tax, for the full year ended March 2018 27
Feb 06, 2018: NATCO records INR 573.6 Crore revenue and INR 217.4 Crore of Profit, after tax, for the Third Quarter, FY 2017-18 28
Aug 07, 2017: NATCO Pharma Reports Financial Results For The Quarter Ended 30 June 2017 29
May 30, 2017: NATCO records INR 2078.9 Crore total consolidated revenue and INR 486.0 Crore of profit, after tax, for the full year ended March 2017 30
Feb 14, 2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017 31
Corporate Communications 32
Aug 07, 2017: Natco Pharma Announces Resignation of Directors 32
Legal and Regulatory 33
Feb 17, 2018: USFDA completes inspection of Natco’s Mekaguda API facility with zero observations 33
Jul 20, 2017: NATCO receives establishment inspection report (EIR) from U.S. food and drug administration (FDA) 34
Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 12
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 13
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 14
Natco Pharma Plans to Raise up to USD232 Million in Public Offering of Shares 15
Natco Pharma Raises USD54.5 Million in Private Placement of Shares 16
Natco Pharma Completes Private Placement Of Shares For US$18 Million 17
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 18
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 19
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 20
Natco Pharma Ltd, Key Competitors 21
Natco Pharma Ltd, Key Employees 22
Natco Pharma Ltd, Other Locations 23
Natco Pharma Ltd, Subsidiaries 23
Natco Pharma Ltd, Joint Venture 24

List of Figures
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★調査レポート[Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C11536)販売に関する免責事項を必ずご確認ください。
★調査レポート[Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆